Clinical Trials Directory

Mifepristone in Refractory Depression

The purpose of the study is to examine the effectiveness of mifepristone treatment in patients with refractory depression. Refractory depression is defined as clinical depression that is unimproved after treatment with at least 2 different antidepressants of adequate dose and time trial. Mifepristone will augment current medications.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • drug : Mifepristone

Phase: Phase 3

Eligibility

Ages Eligible For Study:

18 Years - 75 Years

External Links

Contact information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Jennifer Keller
6507240070
Not Recruiting

Footer Links: